Skip to content
10-Q/A

Quarterly Report

AVAI BIO, INC. AVAI

0001740797-25-000007

← back to feed
Filed
Jan 21, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Sep 3, 2024 121.9M sh
Operating Cash Flow Q1 2025 · Jun 30, 2024 −$12.7K
Operating Cash Flow restated Q1 2025 · Jun 30, 2023 −$59.73K
Cash And Equivalents Q1 2025 · Jun 30, 2024 $444
Cash And Equivalents Q1 2025 · Mar 31, 2024 $281
Stockholders Equity Q1 2025 · Jun 30, 2024 −$2.08M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$1.47M
Stockholders Equity Q1 2025 · Jun 30, 2023 −$993.78K
Stockholders Equity Q1 2025 · Mar 31, 2023 −$633.26K
Current Liabilities Q1 2025 · Jun 30, 2024 $2.33M
Current Liabilities Q1 2025 · Mar 31, 2024 $1.79M
Total Liabilities Q1 2025 · Jun 30, 2024 $2.33M
Total Liabilities Q1 2025 · Mar 31, 2024 $1.79M
Current Assets Q1 2025 · Jun 30, 2024 $58.48K
Current Assets Q1 2025 · Mar 31, 2024 $116.08K
Total Assets Q1 2025 · Jun 30, 2024 $244.89K
Total Assets Q1 2025 · Mar 31, 2024 $322.01K
Eps Basic Q1 2025 · Jun 30, 2024 $0.00
Eps Basic Q1 2025 · Jun 30, 2023 $0.00
Sga Expense Q1 2025 · Jun 30, 2024 $254.67K
Sga Expense Q1 2025 · Jun 30, 2023 $361.49K
Net Income Q1 2025 · Jun 30, 2024 −$528.84K
Net Income Q1 2025 · Jun 30, 2023 −$411.52K